LungLife AI, Inc.
LSE: LLAI.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Paul Pagano
- Employees
- 8
- Headquarters
- Thousand Oaks, United States
- IPO year
- 2021
- Market cap
- £1.3M
- Website
- https://www.lunglifeai.com
Loading LLAI…
Loading profile data…Frequently asked questions about LLAI
What does LungLife AI, Inc. (LLAI.L) do?
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The co...
Where does LLAI.L trade?
LungLife AI, Inc. (LLAI.L) trades on the London Stock Exchange.
What sector is LLAI.L in?
LungLife AI, Inc. (LLAI.L) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of LungLife AI, Inc.?
Paul Pagano is the chief executive officer of LungLife AI, Inc. (LLAI.L).
Where is LungLife AI, Inc. headquartered?
LungLife AI, Inc. is headquartered in United States.
Does LLAI.L pay a dividend?
LungLife AI, Inc. (LLAI.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LLAI.L go public?
LungLife AI, Inc. (LLAI.L) completed its initial public offering in 2021.